Tobii Dynavox AB (publ) (TDVXF)
USD 5.0
(0.0%)
USD 5.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 277 Million | 96.2 Million | 136.5 Million | 272.5 Million | 184.7 Million |
| Net Income | 104 Million | 53.7 Million | 40.5 Million | 103.3 Million | 81 Million |
| Depreciation & Amortization | 64 Million | 124 Million | 95 Million | 87.7 Million | 79.8 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | 9 Million | -83.2 Million | 200 Thousand | 62.8 Million | 5.7 Million |
| Other non-cash items | 100 Million | 1.7 Million | 800 Thousand | 18.7 Million | 18.2 Million |
| Investing Cash Flow | -297 Million | -197.2 Million | -370.3 Million | -102 Million | -108.6 Million |
| Investments in PPE | -135 Million | -118.2 Million | -367.3 Million | -102 Million | -108.6 Million |
| Acquisitions | -164.4 Million | -75.2 Million | - | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | 2.4 Million | -3.8 Million | -3 Million | -78.4 Million | -87.1 Million |
| Financing Cash Flow | 79 Million | 2.5 Million | 253.1 Million | -39.6 Million | -77.6 Million |
| Debt repayment | -99 Million | -25.6 Million | -362 Million | -76.9 Million | -8.4 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | 75 Million | - | - |
| Other Financing Activities | -200 Thousand | 28.1 Million | 540.1 Million | 37.3 Million | -77.6 Million |
| Accounts receivables | -45.4 Million | -52 Million | -20.5 Million | 8.8 Million | -23.5 Million |
| Accounts payables | 76.5 Million | -11 Million | 35.4 Million | 34.9 Million | 48.4 Million |
| Inventory | -21.9 Million | -20.2 Million | -14.7 Million | 19.1 Million | -19.2 Million |
| Other working capital | -200 Thousand | -11 Million | 35.5 Million | 34.9 Million | 48.4 Million |
| Cash at beginning of period | 106.3 Million | 197.3 Million | 172.7 Million | 48.6 Million | 46.1 Million |
| Cash at end of period | 161 Million | 106.8 Million | 197.3 Million | 172.7 Million | 48.6 Million |
| Capital Expenditure | -135 Million | -118.2 Million | -367.3 Million | -102 Million | -108.6 Million |
| Effect of forex changes on cash | -4.7 Million | 8 Million | 6.4 Million | -8 Million | 2.2 Million |
| Net cash flow / Change in cash | 54.7 Million | -90.5 Million | 24.6 Million | 124.1 Million | 2.5 Million |
| Free Cash Flow | 142 Million | -22 Million | -230.8 Million | 170.5 Million | 76.1 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 51 Million | 41 Million | 16 Million | 45 Million | 104 Million | 41 Million |
| Depreciation & Amortization | 49 Million | 48 Million | 47 Million | 21 Million | 64 Million | 43 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -28 Million | -1 Million | -18 Million | 14 Million | 9 Million | -11 Million |
| Other non-cash items | -15 Million | 3 Million | 5 Million | 21 Million | 100 Million | -2 Million |
| Investing Cash Flow | -106 Million | -39 Million | -39 Million | -47 Million | -297 Million | -192 Million |
| Investments in PPE | -49 Million | -40 Million | -40 Million | -39 Million | -135 Million | -38 Million |
| Acquisitions | - | - | - | -8.4 Million | -164.4 Million | -156 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -91 Million | 1 Million | 1 Million | 400 Thousand | 2.4 Million | 2 Million |
| Financing Cash Flow | 25 Million | -21 Million | -50 Million | -25 Million | 79 Million | 145 Million |
| Debt repayment | -60 Million | -15 Million | -43 Million | -21 Million | -99 Million | -152 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -35 Million | -6 Million | -1 Million | 2 Million | -200 Thousand | 297 Million |
| Accounts receivables | - | - | - | -45.4 Million | -45.4 Million | - |
| Accounts payables | - | - | - | -200 Thousand | 76.5 Million | - |
| Inventory | - | - | - | -21.9 Million | -21.9 Million | - |
| Other working capital | -28 Million | -1 Million | -18 Million | 81.5 Million | -200 Thousand | -11 Million |
| Cash at beginning of period | 148 Million | 127 Million | 161 Million | 140 Million | 106.3 Million | 116 Million |
| Cash at end of period | 121 Million | 148 Million | 127 Million | 161 Million | 161 Million | 140 Million |
| Capital Expenditure | -49 Million | -40 Million | -40 Million | -39 Million | -135 Million | -38 Million |
| Effect of forex changes on cash | -3 Million | - | 6 Million | -7.7 Million | -4.7 Million | - |
| Net cash flow / Change in cash | -27 Million | 21 Million | -34 Million | 21 Million | 54.7 Million | 24 Million |
| Free Cash Flow | 8 Million | 41 Million | 10 Million | 62 Million | 142 Million | 33 Million |
OKTA
MAXHEALTH
LTHIF
OX2
MERCURYEV
9103